• 25-Hydroxycholesterol Drives AMPKα Activation in TAMs and Tu

  2026-04-30

  Xiao et al. (2024) uncover a lysosome-centered pathway by which 25-hydroxycholesterol (25HC) activates AMPKα in tumor-associated macrophages (TAMs), reprogramming their metabolism to promote immunosuppression. Modulating this axis reveals new opportunities for enhancing anti-tumor immune responses and combinatorial immunotherapy.

• ALDOB K87 Lactylation Drives Mitochondrial Fission in PH

  2026-04-30

  This study identifies ALDOB K87 lactylation as a critical driver of mitochondrial fission and metabolic reprogramming in pulmonary hypertension (PH). Integrating lactylomic profiling with functional assays, the authors reveal a lactate–ALDOB–DRP1 signaling axis that exacerbates smooth muscle cell proliferation and vascular remodeling, offering new mechanistic targets for PH research.

• Sulfaphenazole: Precision CYP2C9 Inhibitor in Translational

  2026-04-29

  Sulfaphenazole enables rigorous dissection of CYP2C9-mediated drug metabolism and vascular function, while its potent anti-tuberculosis action broadens its translational impact. This guide distills best practices for experimental setup, troubleshooting, and leveraging its dual action in advanced workflows.

• Phosbind Acrylamide for High-Fidelity Protein Phosphorylatio

  2026-04-29

  Phos binding reagent (Phosbind) acrylamide streamlines antibody-free phosphorylation detection, enabling precise mobility shift analysis of key signaling proteins by SDS-PAGE. Its unique phosphate-binding chemistry empowers researchers to dissect complex signaling events and phosphorylation-dependent mechanisms, as exemplified in recent cancer pathway studies.

• D-Luciferin Potassium Salt: Precision in Bioluminescence Ima

  2026-04-28

  D-Luciferin (potassium salt) empowers real-time, non-invasive tracking of tumor and stem cells with unmatched sensitivity and workflow reliability. Its superior solubility and purity drive robust in vivo and in vitro bioluminescence assays, setting the gold standard for translational oncology and advanced immunotherapy research.

• Applied Strategies with GM 6001 (Galardin) for MMP Inhibitio

  2026-04-28

  GM 6001 (Galardin) is a gold-standard MMP inhibitor, empowering precise modulation of extracellular matrix dynamics in cancer, inflammation, and tissue repair models. This article translates cutting-edge evidence and protocol refinements into actionable workflows, with troubleshooting insights for maximizing reproducibility and biological impact.

• Re-evaluating ACE Inhibitors: Selectivity for Aminopeptidase

  2026-04-27

  This article examines Tieku and Hooper's 1992 study, which systematically compared the inhibitory profiles of various metallopeptidase inhibitors—including ACE inhibitors—on three key zinc aminopeptidases (AP-N, AP-A, AP-W) in porcine kidney. Their findings clarify the enzyme selectivity of these inhibitors, with implications for the interpretation of research in hypertension, heart failure, and peptide metabolism.

• Trelagliptin Promotes Osteoblast Differentiation via RUNX2 U

  2026-04-27

  This study demonstrates that trelagliptin, a DPP-4 inhibitor, enhances osteoblastic differentiation in vitro by upregulating RUNX2 and activating the AMPK pathway. These findings suggest a novel therapeutic potential for trelagliptin in osteoporosis, especially for patients with diabetes-related bone loss.

• EZ Cap™ Firefly Luciferase mRNA: Benchmarking Cap 1-Driven A

  2026-04-26

  Explore how EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure enables unprecedented precision in gene regulation reporter assays and in vivo bioluminescence. This article uniquely integrates translational insight from SOD2 mRNA delivery research to redefine best practices for mRNA reporter selection.

• Targeting Antiapoptotic Pathways to Eliminate Senescent Glio

  2026-04-25

  This study demonstrates that inhibiting c-IAP1, c-IAP2, and Bcl-2 selectively eliminates senescent glioblastoma cells after temozolomide therapy. The findings open new avenues for overcoming resistance mechanisms in glioblastoma and refining cell-based models for senescence research.

• Enhanced Antifungal Activity of 13-Benzyl Berberrubine Deriv

  2026-04-24

  The referenced study systematically synthesized and evaluated 13-(substituted benzyl) derivatives of berberine and berberrubine, demonstrating that targeted aromatic modifications at the 13-C position significantly increase antifungal potency—especially against Candida species. These findings offer valuable insight for the rational design of next-generation antifungal agents and illustrate structure–activity relationships relevant to natural isoquinoline alkaloids.

• Oligo (dT) 25 Beads: Technical Guidance for mRNA Isolation

  2026-04-24

  Oligo (dT) 25 Beads address the need for rapid, efficient purification of polyadenylated mRNA from eukaryotic cells and tissues, streamlining workflows for downstream applications such as RT-PCR and library construction. This product is not intended for prokaryotic RNA or non-polyA transcript enrichment, and should not be exposed to freezing conditions. Researchers requiring intact, high-purity mRNA from animal or plant sources will benefit most from this tool.

• Y-27632 Dihydrochloride: Redefining ROCK Inhibition for Plur

  2026-04-23

  Explore the advanced role of Y-27632 dihydrochloride as a selective ROCK inhibitor in establishing intermediate pluripotent stem cells and enabling efficient primordial germ cell induction. This article offers a unique, protocol-driven perspective with actionable insights for stem cell and developmental biology research.

• Tetrandrine Alkaloid: Mechanisms and Benchmarks for Ion Chan

  2026-04-23

  Tetrandrine is a DMSO-soluble alkaloid used in neuroscience and cancer biology research for its robust calcium channel blocking activity. As a bioactive compound, Tetrandrine provides reproducible results in ion channel modulation studies, but requires precise solubility and storage conditions. This article details the molecular mechanism, evidence base, and protocol integration for effective use of Tetrandrine alkaloid in in vitro workflows.

• Dextran Sulfate Sodium Salt (MW 35000-45000): Decoding Epith

  2026-04-22

  Explore how Dextran sulfate sodium salt (MW 35000-45000) advances ulcerative colitis research by uniquely illuminating epithelial repair mechanisms and optimizing preclinical IBD models. This article offers actionable guidance for leveraging DSS in translational studies, grounded in cutting-edge mucosal biology.

16239 records 1/1083 page Next 12345 下5页 Last page